Avoid absolutes when selecting the level of risk for MDM
Question: When calculating risk for an E/M visit, is total parenteral nutrition (TPN) moderate risk or high risk? We found some sources that state it should be compared to prescription drug management, which would be moderate risk. Other sources say it should be compared to drug therapy requiring intensive monitoring for toxicity, which is high risk.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.